Science Applications International
SAIC
122.08
-2.51
-2.01%
Science Applications International
US · SAIC
#2086 by market cap
Listed 1970
122.08
-2.51
-2.01%
Live - 5344 symbols - heartbeat 546s ago
· 2026-10-07 19:54
After-hours
122.08
0.00%
- Market cap
- 5.11B
- P/E (TTM)i
- 14.23
- P/Bi
- 3.56
- EPSi
- 7.70
- Div yieldi
- 1.21%
- 52W posi
- 67%
Reader sentiment
Are you bullish or bearish on SAIC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.91, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -2.90% YoY
Margins
- Gross margin
- 12.01%
- Operating margin
- 7.17%
- Net margin
- 4.93%
Key ratios & quality
- Enterprise valuei
- 7.42B
- PEG ratioi
- 2.34
- Altman Z-Scorei
- 2.91
PEG uses trailing P/E against the 3-year net income growth rate (6.07%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.66B | 6.38B | 7.06B | 7.39B | 7.70B | 7.44B | 7.48B | 7.26B |
| Gross profit | 464.00M | 706.00M | 792.00M | 859.00M | 888.00M | 872.00M | 892.00M | 872.00M |
| Selling & admin expenses | 158.00M | 288.00M | 352.00M | 344.00M | 374.00M | 373.00M | 339.00M | 350.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 306.00M | 418.00M | 444.00M | 516.00M | 514.00M | 501.00M | 563.00M | 521.00M |
| Pretax profit | 170.00M | 286.00M | 271.00M | 358.00M | 375.00M | 620.00M | 428.00M | 387.00M |
| Tax | 33.00M | 57.00M | 60.00M | 79.00M | 72.00M | 143.00M | 66.00M | 29.00M |
| Net profit | 137.00M | 229.00M | 211.00M | 279.00M | 303.00M | 477.00M | 362.00M | 358.00M |
| Basic EPS | 3 | 4 | 4 | 5 | 5 | 9 | 7 | 8 |
| Diluted EPS | 3.11 | 3.83 | 3.56 | 4.77 | 5.38 | 8.88 | 7.17 | 7.70 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 1.88B | 1.77B | 1.87B | 1.75B | 1.91B | 1.88B |
| Gross profit | 209.00M | 215.00M | 227.00M | 221.00M | 249.00M | 239.00M |
| Selling & admin expenses | 89.00M | 75.00M | 101.00M | 85.00M | 83.00M | 87.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 121.00M | 139.00M | 128.00M | 133.00M | 179.00M | 152.00M |
| Pretax profit | 86.00M | 108.00M | 94.00M | 99.00M | 145.00M | 119.00M |
| Tax | 18.00M | -19.00M | 16.00M | 14.00M | 30.00M | 17.00M |
| Net profit | 68.00M | 127.00M | 78.00M | 85.00M | 115.00M | 102.00M |
| Basic EPS | 1 | 3 | 2 | 2 | 3 | 2 |
| Diluted EPS | 1.42 | 2.71 | 1.69 | 1.87 | 2.61 | 2.38 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.43B | 1.43B | 1.29B | 1.26B | 1.20B | 1.13B | 1.15B | 1.18B |
| Cash & ST investments | 237.00M | 188.00M | 171.00M | 106.00M | 109.00M | 94.00M | 56.00M | 182.00M |
| Inventory | 74.00M | 84.00M | 78.00M | 64.00M | 71.00M | -- | -- | -- |
| Total assets | 4.56B | 4.71B | 5.72B | 5.75B | 5.54B | 5.31B | 5.25B | 5.35B |
| Total current liabilities | 897.00M | 1.13B | 1.28B | 1.35B | 1.13B | 1.16B | 1.40B | 982.00M |
| Short-term debt | 24.00M | 70.00M | 68.00M | 148.00M | 31.00M | 77.00M | 313.00M | 19.00M |
| Long-term debt | 2.07B | 1.85B | 2.45B | 2.37B | 2.34B | 2.02B | 1.91B | 2.47B |
| Total liabilities | 3,064,000,000.00 | 3,284,000,000.00 | 4,171,000,000.00 | 4,117,000,000.00 | 3,839,000,000.00 | 3,529,000,000.00 | 3,669,000,000.00 | 3,854,000,000.00 |
| Total equity | 1.50B | 1.43B | 1.55B | 1.63B | 1.70B | 1.79B | 1.58B | 1.50B |
| Retained earnings | 367.00M | 506.00M | 627.00M | 818.00M | 1.04B | 1.43B | 1.57B | 1.49B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 1.15B | 1.20B | 1.26B | 1.18B | 1.20B | 1.28B |
| Cash & ST investments | 47.00M | 48.00M | 45.00M | 182.00M | 109.00M | 126.00M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 5.21B | 5.20B | 5.42B | 5.35B | 5.34B | 5.42B |
| Total current liabilities | 1.47B | 1.45B | 1.05B | 982.00M | 1.04B | 1.06B |
| Short-term debt | 405.00M | 448.00M | 12.00M | 19.00M | 26.00M | 33.00M |
| Long-term debt | 1.88B | 1.84B | 2.48B | 2.47B | 2.46B | 2.45B |
| Total liabilities | 3,706,000,000.00 | 3,684,000,000.00 | 3,911,000,000.00 | 3,854,000,000.00 | 3,915,000,000.00 | 3,987,000,000.00 |
| Total equity | 1.51B | 1.52B | 1.51B | 1.50B | 1.42B | 1.44B |
| Retained earnings | 1.49B | 1.51B | 1.50B | 1.49B | 1.42B | 1.43B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 184.00M | 458.00M | 755.00M | 518.00M | 532.00M | 396.00M | 494.00M | 609.00M |
| Depreciation & amortization | 47.00M | 131.00M | 179.00M | 165.00M | 157.00M | 142.00M | 140.00M | 149.00M |
| Free cash flow | 156.00M | 437.00M | 709.00M | 482.00M | 507.00M | 369.00M | 458.00M | 577.00M |
| Dividends paid | -53.00M | -87.00M | -87.00M | -86.00M | -83.00M | -79.00M | -75.00M | -70.00M |
| Stock buybacks / issuance | -62.00M | -187.00M | -21.00M | -210.00M | -251.00M | -365.00M | -538.00M | -423.00M |
| Ending cash balance | 246.00M | 202.00M | 190.00M | 115.00M | 118.00M | 103.00M | 64.00M | 190.00M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 100.00M | 122.00M | 129.00M | 258.00M | 127.00M | 146.00M |
| Depreciation & amortization | 36.00M | 35.00M | 38.00M | 40.00M | 40.00M | 39.00M |
| Free cash flow | 92.00M | 115.00M | 120.00M | 250.00M | 118.00M | 131.00M |
| Dividends paid | -19.00M | -17.00M | -17.00M | -17.00M | -17.00M | -16.00M |
| Stock buybacks / issuance | -136.00M | -104.00M | -91.00M | -92.00M | -183.00M | -93.00M |
| Ending cash balance | 55.00M | 56.00M | 53.00M | 190.00M | 117.00M | 134.00M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 15.12 | 15.58 | 14.13 | 17.53 | 18.11 | 27.42 | 21.53 | 23.27 |
| ROA %i | 4.13 | 4.87 | 4.01 | 4.83 | 5.31 | 8.79 | 6.86 | 6.75 |
| ROIC %i | 7.30 | 8.41 | 7.82 | 8.35 | 9.28 | 13.80 | 11.71 | 11.68 |
| 5-year avg ROE %i | 35.73 | 31.03 | 27.40 | 23.06 | 16.09 | 18.55 | 19.74 | 21.57 |
| EBIT margin %i | 4.79 | 5.89 | 5.57 | 6.26 | 6.43 | 9.94 | 7.41 | 7.09 |
| FCF / sales %i | 3.35 | 6.85 | 10.05 | 6.52 | 6.58 | 4.96 | 6.12 | 7.95 |
| Current ratioi | 1.60 | 1.27 | 1.01 | 0.93 | 1.06 | 0.98 | 0.83 | 1.20 |
| Quick ratioi | 1.43 | 1.14 | 0.89 | 0.83 | 0.93 | 0.87 | 0.76 | 1.05 |
| Debt / assetsi | 45.78 | 44.43 | 47.53 | 47.16 | 45.57 | 42.27 | 45.62 | 50.15 |
| LT debt / equityi | 139.06 | 142.77 | 171.98 | 158.25 | 147.28 | 121.51 | 131.90 | 177.73 |
| Interest coveragei | 4.21 | 4.18 | 3.22 | 4.41 | 4.13 | 6.17 | 4.40 | 4.02 |
| Revenue CAGR (3Y) %i | 2.59 | 12.82 | 16.57 | 16.64 | 6.49 | 1.80 | 0.38 | -1.95 |
| Net income CAGR (3Y) %i | 5.40 | 16.48 | 5.30 | 26.45 | 9.90 | 31.66 | 9.33 | 6.07 |
| FCF CAGR (3Y) %i | -8.85 | 19.20 | 53.77 | 45.65 | 5.08 | -19.56 | -1.69 | 4.41 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 21.63 | 25.40 | 23.75 | 23.27 | 27.66 | 25.74 |
| ROA %i | 6.75 | 7.64 | 6.94 | 6.75 | 7.68 | 7.15 |
| ROIC %i | 11.50 | 12.97 | 11.98 | 11.68 | 13.03 | 12.11 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.20 | 7.36 | 7.05 | 7.09 | 7.91 | 7.97 |
| FCF / sales %i | 6.10 | 5.91 | 5.81 | 7.95 | 8.27 | 8.36 |
| Current ratioi | 0.78 | 0.83 | 1.20 | 1.20 | 1.16 | 1.20 |
| Quick ratioi | 0.72 | 0.69 | 1.04 | 1.05 | 1.03 | 1.06 |
| Debt / assetsi | 46.84 | 47.01 | 48.79 | 50.15 | 50.11 | 49.88 |
| LT debt / equityi | 135.28 | 131.64 | 174.21 | 177.73 | 186.16 | 186.07 |
| Interest coveragei | 4.43 | 4.50 | 4.21 | 4.02 | 4.40 | 4.44 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Defense and Intelligence is the largest reported line at 77.07% of revenue, across 2 reported segments.
- The next-largest line, Civilian, is a distant second at 22.93% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Defense and Intelligence77.07%
Civilian22.93%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.